Search research articles
Contact Us
Filters
Showing results (181-190 of 288) with videos related to
Page
of 29
Sort By:
Journal of Pharmaceutical Sciences
|
January 1, 1993
Hypolipidemic effects of 6-amino-2-mercapto-5-methylpyrimidine-4-carboxylic acid in rats and tissue culture cells
I H Hall, O T Wong, D J Reynolds, et al.
Journal of Pharmaceutical Sciences
|
November 1, 1989
Hypolipidemic activity of cyclic imido alkyl ethers, thioethers, sulfoxides, and sulfones
J M Chapman, J W Sowell, G Abdalla, et al.
Journal of Pharmaceutical Sciences
|
July 1, 1986
Hypolipidemic activity of N,N-dimethyl-n-octadecylamine borane in rodents
I H Hall, T S Griffin, E L Docks, et al.
Journal of Pharmaceutical Sciences
|
April 1, 1982
Antitumor agents XLVIII: Structure-activity relationships of quassinoids as in vitro protein synthesis inhibitors of P-388 lymphocytic leukemia tumor cell metabolism
Y F Liou, I H Hall, M Okano, et al.
Research Communications in Molecular Pathology and Pharmacology
|
May 23, 2003
Disposition and functions of clarithromycin in human THP-1 monocytes during stimulated and unstimulated conditions
T J Ives, U E Schwab, E S Ward, et al.
Archiv Der Pharmazie
|
May 18, 1999
Investigations on the mechanism of action of the novel antitumor agents 2-benzothiazolyl, 2-benzoxazolyl, and 2-benzimidazolyl hydrazones derived from 2-acetylpyridine
I H Hall, N J Peaty, J R Henry, et al.
Cold Spring Harbor Symposia on Quantitative Biology
|
January 1, 1983
DNA secondary structures: helices, wrinkles, and junctions
S Arnott, R Chandrasekaran, I H Hall, et al.
Pharmaceutical Research
|
August 1, 1993
The hypolipidemic effects of 1-acetyl-4-phenyl-1,2,4-triazolidine-3,5-dione in rodents
I H Hall, R Simlot, P Day, et al.
Biochemical Pharmacology
|
January 15, 1991
In vivo and in vitro effects of helenalin on mouse hepatic microsomal cytochrome P450
D E Chapman, D J Holbrook, S G Chaney, et al.
The Journal of Pharmacy and Pharmacology
|
June 1, 1989
Disposition of the hypolipidaemic agent, 2,3-dihydrophthalazine-1,4-dione, in Sprague Dawley rats
I H Hall, C B Oswald, S D Wyrick, et al.
Page
of 29
Search research articles
Search
Showing results (181-190 of 288) with videos related to
Sort By:
Page
of 29
Journal of Pharmaceutical Sciences
|
January 1, 1993
Hypolipidemic effects of 6-amino-2-mercapto-5-methylpyrimidine-4-carboxylic acid in rats and tissue culture cells
I H Hall, O T Wong, D J Reynolds, et al.
Journal of Pharmaceutical Sciences
|
November 1, 1989
Hypolipidemic activity of cyclic imido alkyl ethers, thioethers, sulfoxides, and sulfones
J M Chapman, J W Sowell, G Abdalla, et al.
Journal of Pharmaceutical Sciences
|
July 1, 1986
Hypolipidemic activity of N,N-dimethyl-n-octadecylamine borane in rodents
I H Hall, T S Griffin, E L Docks, et al.
Journal of Pharmaceutical Sciences
|
April 1, 1982
Antitumor agents XLVIII: Structure-activity relationships of quassinoids as in vitro protein synthesis inhibitors of P-388 lymphocytic leukemia tumor cell metabolism
Y F Liou, I H Hall, M Okano, et al.
Research Communications in Molecular Pathology and Pharmacology
|
May 23, 2003
Disposition and functions of clarithromycin in human THP-1 monocytes during stimulated and unstimulated conditions
T J Ives, U E Schwab, E S Ward, et al.
Archiv Der Pharmazie
|
May 18, 1999
Investigations on the mechanism of action of the novel antitumor agents 2-benzothiazolyl, 2-benzoxazolyl, and 2-benzimidazolyl hydrazones derived from 2-acetylpyridine
I H Hall, N J Peaty, J R Henry, et al.
Cold Spring Harbor Symposia on Quantitative Biology
|
January 1, 1983
DNA secondary structures: helices, wrinkles, and junctions
S Arnott, R Chandrasekaran, I H Hall, et al.
Pharmaceutical Research
|
August 1, 1993
The hypolipidemic effects of 1-acetyl-4-phenyl-1,2,4-triazolidine-3,5-dione in rodents
I H Hall, R Simlot, P Day, et al.
Biochemical Pharmacology
|
January 15, 1991
In vivo and in vitro effects of helenalin on mouse hepatic microsomal cytochrome P450
D E Chapman, D J Holbrook, S G Chaney, et al.
The Journal of Pharmacy and Pharmacology
|
June 1, 1989
Disposition of the hypolipidaemic agent, 2,3-dihydrophthalazine-1,4-dione, in Sprague Dawley rats
I H Hall, C B Oswald, S D Wyrick, et al.
Page
of 29